Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | PALVELLA THERAPEUTICS, INC. | JENKINS GEORGE M
(Director) |
P | Common Stock | A | 4000 | $12.93 - $12.93 | $51,720 |
| 2024-12-12 | PIERIS PHARMACEUTICALS, INC. | GERAGHTY JAMES A
(Director) |
D | Series F Preferred Stock, par value $0.001 per share | D | 1 | $0.01 - $0.01 | $0 |
| 2024-08-07 | PIERIS PHARMACEUTICALS, INC. | GERAGHTY JAMES A
(Director) |
P | Series F Preferred Stock, par value $0.001 per share | A | 1 | $1.00 - $1.00 | $1 |
| 2024-08-09 | PIERIS PHARMACEUTICALS, INC. | ADAR1 Partners, LP
(AtLeastTenPercentOwner) |
P | Common Stock | A | 6000 | $14.89 - $15.88 | $92,324 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |